docetaxel anhydrous has been researched along with Cognitive Decline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Albain, KS; Carlos, RC; Cella, D; Dees, EC; Garcia, SF; Geyer, CE; Goetz, MP; Gray, RJ; Hayes, DF; McCaskill-Stevens, WJ; Minasian, LM; Olson, JA; Pritchard, KI; Sledge, GW; Sparano, JA; Tevaarwerk, AJ; Wagner, LI; Whelan, TJ; Yanez, B | 1 |
| Allen, AR; Brown, T; Byrum, SD; McElroy, T; Ntagwabira, F; Simmons, P; Walters, H; Wang, J | 1 |
| Bian, Y; He, X; Hu, S; Li, J; Miao, H; Partridge, SC; Qiu, B; Ren, J; Yu, Y | 1 |
3 other study(ies) available for docetaxel anhydrous and Cognitive Decline
| Article | Year |
|---|---|
Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx.
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Cognitive Dysfunction; Cyclophosphamide; Docetaxel; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Randomized Controlled Trials as Topic; Tamoxifen | 2020 |
Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cognitive Dysfunction; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Mice; Mice, Inbred C57BL | 2021 |
Long-term cognitive impairment of breast cancer patients after chemotherapy: A functional MRI study.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cognitive Dysfunction; Cyclophosphamide; Docetaxel; Doxorubicin; Executive Function; Female; Gyrus Cinguli; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Middle Aged; Neuropsychological Tests; Occipital Lobe; Prefrontal Cortex; Stroop Test; Taxoids; Temporal Lobe | 2016 |